keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Atosiban (RW22164) 是一种脱氨基催产素类似物,是一种九肽,也是竞争性的催产素受体拮抗剂。它是一种宫缩抑制剂,可用于自发早产的研究。 在相同实验条件下,摩尔浓度相同的化合物盐形式与游离态具有相同的生物活性,但盐形式 Atosiban acetate 的水溶性和稳定性通常比游离态更好。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 270 | 5日内发货 | ||
5 mg | ¥ 587 | 5日内发货 | ||
10 mg | ¥ 840 | 5日内发货 | ||
25 mg | ¥ 1,250 | 5日内发货 | ||
50 mg | ¥ 1,510 | 5日内发货 | ||
100 mg | ¥ 2,260 | 5日内发货 | ||
1 mL * 10 mM (in DMSO) | ¥ 919 | 5日内发货 |
Atosiban 的其他形式现货产品:
产品描述 | Atosiban (RW22164) is an inhibitor of the hormones oxytocin and vasopressin. It is used as an intravenous medication as a labour repressant (tocolytic) to halt premature labor. Atosiban inhibits the oxytocin-mediated release of inositol trisphosphate from the myometrial cell membrane. As a result, there is reduced release of intracellular, stored calcium from the sarcoplasmic reticulum of myometrial cells, and reduced influx of Ca2+ from the extracellular space through voltage gated channels. In addition, atosiban suppresses oxytocin-mediated release of PGE and PGF from the decidua. In human pre-term labor, atosiban, at the recommended dosage, antagonizes uterine contractions and induces uterine quiescence. The onset of uterus relaxation following atosiban is rapid, uterine contractions being significantly reduced within 10 minutes to achieve stable uterine quiescence. |
别名 | 阿托西班, RWJ22164, RW22164 |
分子量 | 994.19 |
分子式 | C43H67N11O12S2 |
CAS No. | 90779-69-4 |
keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 16.67 mg/mL (16.77 mM), Sonication is recommended.
DMSO: 16.67 mg/mL (16.77 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
H2O / DMSO | 1 mM | 1.0058 mL | 5.0292 mL | 10.0584 mL | 25.1461 mL |
5 mM | 0.2012 mL | 1.0058 mL | 2.0117 mL | 5.0292 mL | |
10 mM | 0.1006 mL | 0.5029 mL | 1.0058 mL | 2.5146 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Atosiban 90779-69-4 Endocrinology/Hormones GPCR/G Protein Oxytocin Receptor Vasopressin Receptor nonapeptide desamino-oxytocin OXTR vasopressin tocolytic RWJ 22164 Ca2+ Preterm Inhibitor maternal-fetal inhibit 阿托西班 RWJ22164 RW-22164 RWJ-22164 oxytocin RW22164 RW 22164 inhibitor